(Sharecast News) - Diagnostic tests manufacturer Abingdon Health has entered into a strategic partnership with lateral flow technology group Senzo.
Abingdon said on Monday that its deal with Senzo will see it provide contract development and manufacturing services to both it and its partners as part of an effort to enable them to develop and manufacture new rapid tests utilising its "cutting-edge ALF platform".
Financial terms of the deal were not disclosed.
Chief executive Chris Yates said: "We are really excited to be working with Senzo and supporting them in leveraging their cutting-edge lateral flow platform technology across multiple applications.
"We believe this strategic partnership agreement provides Senzo Health and its customers with access to Abingdon's best-in-class CDMO service to enable accelerated product development and time to market."
As of 1000 GMT, Abingdon shares were down 0.19% at 5.24p.
Reporting by Iain Gilbert at Sharecast.com
Abingdon Healt. (ABDX)